Insiders · CYCC

CYCC insider transactions

Cyclacel Pharmaceuticals Inc. (CYCC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CYCC

• 221d
  New insider Fitters Diversified Berhad claimed ownership of 699,158 shares (SEC Form 3)

  3 - Bio Green Med Solution, Inc. (0001130166) (Issuer)
• 227d
  Large owner Kua Khai Loon sold $133,569 worth of shares (19,054 units at $7.01), decreasing direct ownership by 5% to 385,411 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 233d
  Large owner Ong Yee Lung acquired 186,465 shares, increasing direct ownership by 86% to 404,465 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 233d
  Large owner Yap Kim Choy acquired 186,465 shares, increasing direct ownership by 86% to 404,465 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 233d
  Large owner Kua Khai Loon acquired 186,465 shares, increasing direct ownership by 86% to 404,465 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 236d
  New insider Ong Yee Lung claimed ownership of 218,000 shares (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 236d
  New insider Kua Khai Loon claimed ownership of 218,000 shares (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 236d
  New insider Yap Kim Choy claimed ownership of 218,000 shares (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 264d
  Large owner Lazar David E. sold $83,430 worth of shares (6,750 units at $12.36), decreasing direct ownership by 4% to 155,838 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 330d
  Amendment: SEC Form 3 filed by new insider Tan Kok Hui

  3/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 330d
  Amendment: SEC Form 3 filed by new insider Suria Sukses Engineering Sdn Bhd

  3/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 330d
  Amendment: SEC Form 3 filed by new insider Ho Kee Wee

  3/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 330d
  Amendment: SEC Form 3 filed by new insider Ho Jien Shiung

  3/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 345d
  New insider Ho Jien Shiung claimed ownership of 250,000 units of Cyclacel Common Stock (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 345d
  New insider Ho Kee Wee claimed ownership of 250,000 units of Cyclacel Common Stock (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 346d
  New insider Tan Kok Hui claimed ownership of 250,000 units of Cyclacel Common Stock (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 358d
  New insider Laurduraj Inigo Angel claimed no ownership of stock in the company (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 358d
  New insider Suria Sukses Engineering Sdn Bhd claimed ownership of 250,000 units of Cyclacel Common Stock (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 358d
  New insider Nair Krishnan Satis Waran claimed no ownership of stock in the company (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 421d
  SEC Form 4 filed by Director Natan David

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 421d
  Interim CEO Lazar David E. converted options into 194,628,820 shares and sold $5,507,996 worth of shares (194,628,820 units at $0.03) (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 421d
  SEC Form 4 filed by Director Ben-Tzvi Avraham

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 421d
  New insider Doris Wong Sing Ee claimed ownership of 194,628,820 shares (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 421d
  New insider Chong Kwang Fock claimed no ownership of stock in the company (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 421d
  New insider Kiu Cu Seng claimed no ownership of stock in the company (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 439d
  SEC Form 4 filed by Interim CEO Lazar David E.

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 472d
  New insider Ben-Tzvi Avraham claimed no ownership of stock in the company (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 473d
  Director Natan David was granted 100,000 shares (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 473d
  New insider Natan David claimed no ownership of stock in the company (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 473d
  New insider Lazar David E. claimed no ownership of stock in the company (SEC Form 3)

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 815d
  Schwartz Brian was granted 12,500 shares, increasing direct ownership by 462% to 15,205 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 851d
  Rombotis Spiro George bought $20,122 worth of shares (6,070 units at $3.31), increasing direct ownership by 10% to 68,658 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 851d
  Mcbarron Paul bought $6,252 worth of shares (1,886 units at $3.31), increasing direct ownership by 6% to 33,378 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1027d
  SEC Form 4 filed by Rombotis Spiro George

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1027d
  SEC Form 4 filed by Barker Sam L

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1027d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1027d
  SEC Form 4 filed by Mcbarron Paul

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1027d
  SEC Form 4 filed by Kirschbaum Mark

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1027d
  SEC Form 4 filed by Walker Karin L

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1027d
  SEC Form 4 filed by Ferguson Kenneth M.

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1027d
  SEC Form 4 filed by Henney Christopher S

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1027d
  SEC Form 4 filed by Schwartz Brian

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1178d
  SEC Form 4: Mcbarron Paul was granted 31,200 shares, increasing direct ownership by 10,685% to 31,492 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1178d
  SEC Form 4: Rombotis Spiro George was granted 57,600 shares, increasing direct ownership by 1,155% to 62,588 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1178d
  SEC Form 4: Kirschbaum Mark was granted 31,200 shares

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1408d
  SEC Form 4: Ferguson Kenneth M. was granted 23,733 shares (Amendment)

  4/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1409d
  SEC Form 4: Ferguson Kenneth M. was granted 27,733 shares

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1409d
  SEC Form 3 filed by new insider Ferguson Kenneth M.

  3 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1409d
  SEC Form 4: Walker Karin L was granted 15,822 shares, increasing direct ownership by 444% to 19,383 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1409d
  SEC Form 4: Spiegel Robert J. was granted 15,822 shares, increasing direct ownership by 666% to 18,196 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1409d
  SEC Form 4: Sems Lloyd was granted 15,822 shares, increasing direct ownership by 666% to 18,196 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1409d
  SEC Form 4: Schwartz Brian was granted 15,822 shares, increasing direct ownership by 444% to 19,383 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1409d
  SEC Form 4: Henney Christopher S was granted 15,822 shares, increasing direct ownership by 666% to 18,196 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1409d
  SEC Form 4: Barker Sam L was granted 15,822 shares, increasing direct ownership by 469% to 19,196 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1591d
  SEC Form 4 filed by Rombotis Spiro George (Amendment)

  4/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1592d
  SEC Form 4 filed by Rombotis Spiro George

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1592d
  SEC Form 4 filed by Mcbarron Paul

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1592d
  SEC Form 4 filed by Kirschbaum Mark

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1605d
  SEC Form 4: Barker Sam L sold $43 worth of shares (12 units at $3.57), decreasing direct ownership by 0.35% to 3,374 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1615d
  SEC Form 4: Rombotis Spiro George bought $18,000 worth of shares (4,000 units at $4.50), increasing direct ownership by 405% to 4,988 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)